ReNeuron Group PLC is a United Kingdom-based adult stem cell research and development company.  The Company is applying its novel stem cell platform technologies in the development of stem cell therapies to serve significant and unmet or poorly-met clinical needs.  ReNeuron Group has also leveraged its stem cell technologies into the non-therapeutic areas such as drug discovery.

Corporate update and AIM cancellation 

Corporate Update

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Reneuron (RENE LN)

Corporate update and AIM cancellation

Corporate Update

Change of Registered Address

Creditor’s decision on Administrators' Proposals

Publication of Joint Administrators' Proposals

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)